SHANGHAI, Aug. 11, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of WuXia293 Stable ...
"This opens a new way to build more reliable living systems, from stable cell factories to future medical applications," Tian says. "Our strategy can become a new design principle for researchers who ...
"This opens a new way to build more reliable living systems, from stable cell factories to future medical applications," Tian says. "Our strategy can become a new design principle for researchers who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results